Board Members

Prakash Sampath

Founder and President of the Rhode Island Brain and Spine Tumor Foundation (RIBSTF) currently serves as Chief of Neurosurgery at Roger Williams Medical Center and is Associate Professor of Neurological Surgery at Boston University School of Medicine, as well as, Associate Professor (Adjunct) in Neurosurgery at Brown Alpert Medical School at Brown University. After receiving his undergraduate degree in biomedical engineering from John Hopkins University in Baltimore, he completed his medical degree at Columbia University College of Physicians and Surgeons in New York City. He then completed his internship in general surgery and his residency in Neurosurgery at John Hopkins Hospital, as well as, a fellowship in Neuro-Oncology (brain tumors). Currently, Dr. Sampath specializes in all aspects of adult neurosurgery with an emphasis on brain tumors, spinal oncology and complex spine surgery.

Arieana Carcieri

Arieana Carcieri is a board certified nurse practioner who specializes in Neuro-Oncology at the Lifespan Cancer Institute at Rhode Island Hospital. Arieana completed her Bachelor of Science in Nursing and Master of Science in Nursing at Mass General Hospital Institute of Health Professionals in Boston, Massachusetts. She also earned a Bachelor of Science in Nutrition from the University of Rhode Island. Arieana holds a national certificaiton with the American Nurses Credentialing Center (ANCC).

Vaishali Khamamkar

Vaishali Khamamkar is statistical analyst by profession , graduated as Masters in Bioinformatics and works in healthcare field in MA. Joined RIBSTF in the virtue of returning help and care she received from everyone while her father was diagnosed with GBM.

Suriya Jeyapalan

Dr. Suriya Jeyapalan, MD serves as the Director of Medical Neuro-Oncology at Tufts Medical Center where she specializes in neurology and oncology. As a University of Iowa medical graduate, Dr. Jeyapalan went on to earn her Master of Public Health (MPH) from Harvard School of Public Health. She fulfilled her internship in Medicine at the University of Iowa Hospitals and Clinics, followed by her residency in Neurology at Columbia-Presbyterian Medical Center and her fellowship in Neuro-Oncology at Massachusetts General Hospital. Currently, she focuses her research in genomics to determine the genetic basis of chemotherapeutic response in patients with high-grade gliomas. She also leads clinical trials in the treatment of malignant gliomas and metastatic disease to the brain.

Philip R Morin, BS, MBA (finance)

Currently retired. Forty five year career in the Plastics Industry. Work experience included product management, marketing and sales management, and strategic planning. In addition to RISBTF, other current volunteer activities include “Meals on Wheels” and SCORE, a resource partner of the Small Business Administration, providing counseling to small businesses in Rhode Island. Lost my wife, Phyllis, three years ago to GBM brain tumor.

Douglas Anthony, MD, PhD

Douglas Anthony, MD, PhD, is the chief of pathology and laboratory medicine at Lifespan and professor at Warren Alpert Medical School. In these roles, he is responsible for diagnostic testing within the hospitals and clinics of Lifespan and educational and research programs in diagnostic testing. He trained at Duke University and was on the faculty at Duke before moving to Boston to join the faculty of Harvard Medical School and assume leadership roles in pathology at Children’s Hospital and Brigham and Women’s Hospital. He joined Lifespan and the Brown faculty in 2012. Lifespan Laboratories performs over 12 million tests per year, serving patients and physicians across the state of Rhode Island. The labs have an extensive menu of molecular testing to provide personalized treatments for patients based on their unique genetic profile, an approach known as precision medicine. Dr. Anthony is the author of over 140 publications and has given invited lectures across the US, Asia, Europe, and South America about pathology and diagnostic testing. He has received multiple grants for his research over the years, his current research is in the field of brain tumors. He is the Past President of the New England Society of Pathologists, and Vice President of the American Association of Neuropathologists.